Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Sunshine Biopharma Inc. Warrant
SBFMW | US
0.09
USD0
0%
SBFMW | US
About Sunshine Biopharma Inc. Warrant
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
20/03/2026
Close
0.09
Open
0.09
High
0.09
Low
0.09
Sunshine Biopharma Inc. a pharmaceutical company focuses on the research and development of life-saving medicines in various therapeutic areas including oncology and antivirals. The company is developing Adva-27a a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia lymphoma testicular lung brain prostate bladder colon ovarian liver and other forms of cancers as well as kills multidrug resistant cancer cells including pancreatic cancer breast cancer small-cell lung cancer and uterine sarcoma cells; SBFM-PL4 an anti-coronavirus treatment compound; and K1.1 mRNA molecules used as anti-cancer agents. It also offers Essential 9 an amino acids capsules; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name as well as develops and markets other science-based nutritional supplements. Sunshine Biopharma Inc. is based in Pointe-Claire Canada.
View LessSBFMW | US
Risk
326.0
Sharpe
-0.14
Luna's Score
46/100
Recommendation
Hold
Luna says (SBFMW | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
342.6%1 month
326.0%3 months
307.1%6 months
322.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-4.40M
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-13.63
Erngs. growth
-
Rev. growth
67.30
Ret. on equity
-15.79
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.03
Range1M
0.19
Range3M
0.26
Volumes: Market Activity
Rel. volume
0.11
Price X volume
93.70
